No black box warning on record for Bumetanide

As of the latest FDA labeling reviewed, Bumetanide (BUMETANIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Bumetanide medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Volume and Electrolyte Depletion The dose of bumetanide should be adjusted to the patient’s need. Excessive doses or too frequent administration can lead to profound water loss, electrolyte depletion, dehydration, reduction in blood volume and circulatory collapse with the possibility of vascular thrombosis and embolism, particularly in elderly patients. Hypokalemia Hypokalemia can occur

No black box warning on record for Bumetanide

Other warnings & precautions

WARNINGS Volume and Electrolyte Depletion The dose of bumetanide should be adjusted to the patient’s need. Excessive doses or too frequent administration can lead to profound water loss, electrolyte depletion, dehydration, reduction in blood volume and circulatory collapse with the possibility of vascular thrombosis and embolism, particularly in elderly patients. Hypokalemia Hypokalemia can occur

Bumetanide Black Box Warning

No black box warning on record for Bumetanide

Other warnings & precautions

Bumetanide Black Box Warning

No black box warning on record for Bumetanide

Other warnings & precautions